Clinical trials in Bron – page 4

472 clinical trials in Bron, France across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in FranceEssaisCliniques.fr

Bron at a glance

472

clinical trials

Research sites3

Quick filters

472 trials in Bron

Open in trial search

Idiopathic pulmonary fibrosis

Recruiting

Investigational

A study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis

Investigational

France

Participants:18–64 years · 65+ years
Substances:HUMANISED IGG1 LALAPS-YTE MONOCLONAL ANTIBODY AGAINST LYSOPHOSPHATIDIC ACID RECEPTOR 1
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Interstitial lung disease+1

Recruiting

Investigational

A study to evaluate the effectiveness of BI 1015550 in people with lung abnormalities and a family history of pulmonary fibrosis

Investigational

France

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Bi 1015550
Sponsor:Boehringer Ingelheim International GmbH

Contact Research Centre

Secondary progressive multiple sclerosis

Recruiting

Investigational

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Investigational

France

Participants:18–64 years · 65+ years
Substances:Remibrutinib
Sponsor:Novartis Pharma AG

Contact Research Centre

Colitis ulcerative

Recruiting

InvestigationalNo placebo

A study to evaluate the efficacy and safety of etrasimod arginine in children with moderately to severely active ulcerative colitis

InvestigationalNo placebo

France

Participants:0–17 years
Substances:Etrasimod Arginine
Sponsor:Pfizer Inc.

Contact Research Centre

Short stature+1

Recruiting

Registered drugNo placebo

Study of Lonapegsomatrin and Somatropin in Children and Adolescents with Short Stature or Growth Failure due to Turner Syndrome, SHOX Deficiency, SGA, or Idiopathic Short Stature

Registered drugNo placebo

France

Participants:0–17 years
Substances:Lonapegsomatropin
Sponsor:Ascendis Pharma Endocrinology Division A/S

Contact Research Centre

Breast cancer metastatic

Recruiting

Registered drug

A study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Letrozole
Sponsor:Olema Pharmaceuticals Inc.

Contact Research Centre

Cerebral haemorrhage

Recruiting

Registered drug

A study to evaluate the use of diroximel fumarate to reduce brain swelling in patients with a stroke caused by bleeding in the brain.

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Diroximel Fumarate
Sponsor:Centre Hospitalier Universitaire De Lille

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Study comparing firmonertinib with osimertinib or afatinib for patients with advanced lung cancer with uncommon EGFR mutations

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Afatinib
Sponsor:Arrivent Biopharma Inc.

Contact Research Centre

Glycogen storage disease type II

Recruiting

Investigational

A Study of S-606001 Added to Enzyme Replacement Therapy for Patients with Late-Onset Pompe Disease

Investigational

France

Participants:18–64 years
Sponsor:Shionogi B.V.

Contact Research Centre

Adrenogenital syndrome

Recruiting

Investigational

A Study Testing Atumelnant Compared to Placebo in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Steroid Dose While Controlling Hormones

Investigational

France

Participants:18–64 years · 65+ years
Substances:ATUMELNANT
Sponsor:Crinetics Pharmaceuticals Inc.

Contact Research Centre

Type IIa hyperlipidaemia

Recruiting

Investigational

A Study of Enlicitide for Safety and Effectiveness in Children and Adolescents with Heterozygous Familial Hypercholesterolemia

Investigational

France

Participants:0–17 years
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Cardiac amyloidosis

Recruiting

Investigational

A study of coramitug compared to placebo for people with heart failure caused by transthyretin amyloid cardiomyopathy

Investigational

France

Participants:18–64 years · 65+ years
Sponsor:Novo Nordisk A/S

Contact Research Centre

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Bron

What the registry says about research in the country

01 Neurological Disorders

Innovative research focusing on multiple sclerosis and Parkinson's disease, including advanced PET imaging studies and evaluation of novel therapeutic approaches.

Multiple Sclerosis Imaging
Parkinson's Disease Treatment
Essential Tremor Studies

Studies include neuroinflammation assessment and serotonergic receptor expression analysis.

02 Brain Tumors

Comprehensive research into glioblastoma treatment approaches, combining innovative therapies with standard protocols.

Newly Diagnosed Glioblastoma
Nanoparticle Therapy
Combined Treatment Approaches

Integration of radiotherapy, chemotherapy, and novel therapeutic agents for improved patient outcomes.

03 Rare Diseases

Targeted research on rare conditions including Dravet Syndrome and Alagille syndrome, focusing on innovative therapeutic approaches.

Hereditary Conditions
Genetic Disorders
Novel Treatment Evaluation

Emphasis on developing effective treatments for previously undertreated rare conditions.

Back to France All countries